KRYS - Krystal Biotech, Inc.
260.33
-4.670 -1.794%
Share volume: 276,507
Last Updated: 03-05-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$265.00
-4.67
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-06-2024 | 08-05-2024 | 11-04-2024 | 02-19-2025 | 05-06-2025 | 08-04-2025 | 11-03-2025 | 02-17-2026 | |
| Cash flow financing | 10.583 M | 10.638 M | 3.365 M | 2.428 M | -12.466 M | 1.796 M | 3.709 M | 15.666 M | |
| Other financing cash flows | 10.583 M | 10.638 M | 3.365 M | 2.428 M | -12.466 M | 1.796 M | 3.709 M | 15.666 M | |
| Cash flow | 491.000 K | -12.883 M | 27.894 M | -28.507 M | -36.266 M | 44.000 M | 39.082 M | 104.337 M | |
| Net income | 932.000 K | 15.568 M | 27.180 M | 45.479 M | 35.733 M | 38.333 M | 79.365 M | 51.400 M | |
| Depreciation | 1.427 M | 1.835 M | 1.341 M | 1.364 M | 1.410 M | 1.349 M | 1.403 M | 1.562 M | |
| Changes in inventories | 2.238 M | 0.000 | 0.000 | 0.000 | 1.395 M | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -25.980 M | -19.353 M | -34.328 M | -83.778 M | -54.769 M | -10.525 M | -4.286 M | 11.163 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 1.260 M | 1.131 M | 1.046 M | 801.000 K | 5.769 M | 1.904 M | 1.704 M | 2.139 M | |
| Cash Change | 678.000 K | -13.220 M | 28.180 M | -29.101 M | -36.095 M | 45.059 M | 38.775 M | 103.700 M |